Your session is about to expire
← Back to Search
Spinal Cord Stimulation for Chronic Pain (MOPPStim Trial)
MOPPStim Trial Summary
This trial is testing a new way to treat chronic pain by stimulating different pathways in the spinal cord. They hope to understand the mechanisms of therapeutic benefit and identify criteria for selecting patients.
MOPPStim Trial Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowMOPPStim Trial Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From 2019 Phase 4 trial • 30 Patients • NCT03284411MOPPStim Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- You have had ongoing pain that hasn't improved with regular treatments for at least 3 months.You have instability in your spine that can be seen in certain X-rays.You have pain rated higher than 3 out of 10 and a disability score higher than 40 out of 100.You are currently involved in legal issues related to the pain.You have ongoing nerve or muscle problems, or pain related to nerve damage (like after a stroke).You are either younger than 18 or older than 80 years old.You have participated in a previous trial or have had a spinal cord stimulation system implanted.You have had extensive surgery on your upper or lower back, have a narrowing of the spinal canal, have bleeding problems, or have an infection in your back or elsewhere in your body.You are taking more than 200 milligrams of opioid medication per day.Adults between 18 and 80 years old who have had ongoing, severe nerve pain in their back and/or legs for more than 3 months after having surgery on their lower spine.You have a mental health condition that may affect how you feel pain.
- Group 1: Spinal Cord Stimulation
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Is this trial limited to a certain age range?
"The requirements for this medical trial restrict participation to individuals aged 18-80. Meanwhile, 40 clinical trials are tailored towards minors and 480 studies offer treatments specifically designed for the elderly."
Are there any open spots remaining in this clinical trial?
"Affirmative. Clinicaltrials.gov states that this clinical examination is actively seeking participants, with the first advertisement dating back to May 16th 2019 and the most recent update being on October 31st 2022. A total of 90 individuals are needed for 1 site."
To whom does this experiment offer enrollment opportunities?
"This clinical trial is accepting 90 adult patients, aged between 18 and 80, who have suffered from refractory neuropathic pain in the back or lower limbs for more than 3 months due to lumbar spine surgery. To qualify for this study, a patient must present with chronic pain of at least 3/10 on NRS scale and an ODI score above 40/100 that has not improved with conventional treatments over the last three months."
What is the intake size for this experiment?
"Affirmative. The details posted on clinicaltrials.gov indicate that recruitment for this study is ongoing, with the initial advertisement published on 16 May 2019 and the most recent update occurring at 31 October 2022. This trial requires 90 volunteers to be enrolled from 1 medical facility."
Share this study with friends
Copy Link
Messenger